These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7995916)

  • 1. [RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
    Werner H; Hohlfeld P; Jacquemard F; Mirlesse V; Menez D; Daffos F
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):701-5. PubMed ID: 7995916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
    Pons JC; Rais S; Diochin P; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):255-7. PubMed ID: 1583307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
    Ebbers S; Creemers JW; Lotgering FK
    Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
    D'Ercole C; Blanc B; Boubli L; Bautrant E; Nadal F; Eyraud B
    Rev Fr Gynecol Obstet; 1992 May; 87(5):277-80. PubMed ID: 1626173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
    Jansen NE; Pasker-De Jong PC; Zondervan HA
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):847-51. PubMed ID: 18979392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
    Ho PC; Ma HK
    Contraception; 1993 Feb; 47(2):123-9. PubMed ID: 8449013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mifepristone and misoprostol in therapeutic abortions].
    Jannet D; Aflak N; Chemla JP; Marpeau L; Milliez J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):277-82. PubMed ID: 8767226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
    Kanhai HH; Keirse MJ
    Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Stoutjesdijk JA; Alsma J; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative use of analogs of prostaglandin by intravenous or vaginal administration in termination of pregnancy].
    Poulain P; Blanchot J; Roze JM; Babatasi S; Grall JY
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):223-7. PubMed ID: 2182703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
    Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
    Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic termination of second trimester pregnancies with low dose misoprostol.
    Liaquat NF; Javed I; Shuja S; Shoaib T; Bano K; Waheed S; Ansar A
    J Coll Physicians Surg Pak; 2006 Jul; 16(7):464-7. PubMed ID: 16827957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women].
    Schaub B; Fuhrer P; Sainte-Rose D
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):505-10. PubMed ID: 7499737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.
    Gemzell-Danielsson K; Ostlund E
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):702-6. PubMed ID: 10949238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic abortion during the 2nd and 3rd trimesters of pregnancy using a synthetic derivative of prostaglandin E2, sulprostone, administrated intravenously. Based upon 182 cases.
    Marpeau L; Percque M; Larue L; Guettier X; Jault T; Pigne A; Barrat J
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):99-103. PubMed ID: 8405648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.